Bullous Pemphigoid Clinical Trials

63 clinical trials for Bullous Pemphigoid across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) — RECRUITING · PHASE1
• Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) — RECRUITING · PHASE1
• Comparison of the therapeutic responsiveness of patients with BP180-reactive bullous pemphigoid (BP) and patients with BP230-reactive BP. — RECRUITING
• Autoimmune Blistering Diseases Study — RECRUITING
• Adjuvant therapy of severe and/or refractory bullous pemphigoids with immunoadsorption by LIGASORB®, dapsone, prednisolone and topical mometasone fumarate (LiBPem-Study). — RECRUITING
• A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid — COMPLETED · PHASE2
• Association Between Disease Severity and Clinical, Histopathological, and Eosinophilic Markers in Patients With Bullous Pemphigoid (BP-EPIC) — ACTIVE_NOT_RECRUITING
• Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid — COMPLETED · PHASE4
• Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid — COMPLETED · PHASE3
• Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid — COMPLETED · PHASE3
• Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody — COMPLETED · PHASE2
• A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid — TERMINATED · PHASE3
• Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid — COMPLETED · PHASE4
• A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid — COMPLETED · PHASE2
• Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid — NOT_YET_RECRUITING · PHASE3
• Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients. — COMPLETED
• Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid — COMPLETED · PHASE4
• Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoid A prospective multi-centre randomised double-blind placebo-controlled pilot study — OTHER
• Retrospective study to characterize patients with bullous pemphigoid presenting as eczema and prurigo diseases — NOT_YET_RECRUITING
• Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid — OTHER
• Testing of a new test system for diagnosis and therapy planning of severe blistering autoimmune diseases of the skin — OTHER
• rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects — COMPLETED · PHASE2
• Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) — WITHDRAWN · PHASE3
• An Open-label Extension Study of ARGX-113-2009 to Evaluate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid — OTHER · PHASE3
• A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid. — TERMINATED · PHASE3
• Trace element analyses in inflammatory and autoimmune skin diseases — NOT_YET_RECRUITING
• JAK Inhibitors' Efficacy in Bullous Pemphigoid — COMPLETED
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid — OTHER · PHASE3
• A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid — OTHER · PHASE3
• DERMOS study : Influence of dermocorticoids on bone mineral density in patients with bullous pemphigoid. — TERMINATED · PHASE4
• Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid — WITHDRAWN · PHASE3
• Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid — OTHER · NA
• Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid — COMPLETED
• Retrospective Study of the Effects of Sub-pathologic Phenotypes of BP on Clinical Management and Prognosis — OTHER
• Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid — TERMINATED · PHASE2
• Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid — COMPLETED
• Telederm and Bullous Pemphigoid — COMPLETED
• A PHASE 2/3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF EFGARTIGIMOD PH20 SC IN ADULT PARTICIPANTS WITH BULLOUS PEMPHIGOID — NOT_YET_RECRUITING · PHASE2
• Efficacy and Safety of Ustekinumab in Bullous Pemphigoid — COMPLETED · PHASE2
• A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF NIPOCALIMAB FOR THE TREATMENT OF ADULT PARTICIPANTS WITH MODERATE TO SEVERE BULLOUS PEMPHIGOID — NOT_YET_RECRUITING · PHASE2
• Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid — OTHER · PHASE3
• Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid — OTHER
• Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders — COMPLETED · PHASE1
• Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population — OTHER
• Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy — OTHER
• The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors — OTHER
• Ixekizumab in the Treatment of Bullous Pemphigoid — COMPLETED · PHASE2
• A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid — TERMINATED · PHASE2
• A mechanistic study to determine the relevance of Benralizumab targets (eosinophil-numbers and IL5-receptor) in patients with skin disorders. — OTHER
• Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid — COMPLETED

Refine this search